Fundraising FoxCoreTissue BioEngineering
1 known investors
Find your way into CoreTissue BioEngineering
Sign up to see every warm intro you have to CoreTissue BioEngineering
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoreTissue BioEngineering team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CoreTissue BioEngineering develops a tissue-regenerating ligament implant for anterior cruciate ligament (ACL) reconstruction, using a proprietary decellularization technology to regenerate damaged tissue. The company aims to help athletes return to competition and recover peak performance, and is developing its medical device in Japan.
Investors · 1
Frequently asked questions
- What does CoreTissue BioEngineering do?
- CoreTissue BioEngineering develops a tissue-regenerating ligament implant for anterior cruciate ligament (ACL) reconstruction, using a proprietary decellularization technology to regenerate damaged tissue. The company aims to help athletes return to competition and recover peak performance, and is developing its medical device in Japan.
- Who are CoreTissue BioEngineering's investors?
- CoreTissue BioEngineering's investors include Mitsui Sumitomo Insurance Capital.